Moderate riskFDA DrugClass II

TRIPENICOL S antifungal solution recalled for missing stability testing

FDA announced a recall of TRIPENICOL S Antifungal Solution, a 1.25 fl oz bottle manufactured for Trifluent Pharma, LLC. The firm discontinued required stability testing for products still within their expiration date, which FDA classifies as a CGMP deviation. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Stop using bottles from lot BL3411R with expiration date 6/8/2027 (NDC 73352-550-01).
  2. Check the bottle label for lot BL3411R, expiration 6/8/2027, and NDC 73352-550-01.
  3. The notice doesn't say how to get a refund or replacement; contact Blaine Labs Inc, Trifluent Pharma, or where you bought it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle, Manufactured For: Trifluent Pharma, LLC, San Antonio, TX 78213, NDC 73352-550-01.
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 8 products — see all of them.

Details

Units affected
144 bottles
Illnesses reported
None reported
Manufactured in
11037 Lockport Pl, N/A, Santa Fe Springs, CA, United States
Classification
Class II
Recall number
D-0694-2026

In the FDA's words

Description
TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle, Manufactured For: Trifluent Pharma, LLC, San Antonio, TX 78213, NDC 73352-550-01. CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry Lot #BL3411R, Exp 6/8/2027 Distribution: Nationwide in the USA Affected quantity: 144 bottles
Hazard
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

8 products in this recall

Revitaderm, Terpenicol and more recalled for microbial contamination

Eight Blaine Labs and Trifluent Pharma wound care and antifungal products are recalled: Revitaderm, TRIDERGEL, TRIPENICOL S, TERPENICOL, vite20, Fungal Fusion and Revitaderm First Aid Antiseptic Gel. Samples of these non-sterile products showed Lysinibacillus fusiformis and other Bacillus species. The FDA has classified this as a Class I recall.

The agency lists each product separately. Check every one you might have.

Related topics

OtherPotencySterilityDrugsSold nationwideMore from FDA Drug